IBOTTA INC-CL A (IBTA) Stock Analyst Ratings
USA - NYSE:IBTA - US4510511060 - Common Stock
26.56 USD
+1.58 (+6.33%)
25.51 USD
-1.05 (-3.95%)
ChartMill assigns a Buy % Consensus number of 51% to IBTA. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 29.73. This target is 11.92% above the current price.
IBTA was analyzed by 14 analysts. The buy percentage consensus is at 51. So analysts seem to be rather neutral about IBTA.
In the previous month the buy percentage consensus was at a similar level.
IBTA was analyzed by 14 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-11-13 | Evercore ISI Group | Maintains | In-Line -> In-Line |
| 2025-11-13 | Goldman Sachs | Maintains | Sell -> Sell |
| 2025-11-13 | B of A Securities | Maintains | Underperform -> Underperform |
| 2025-10-15 | Goldman Sachs | Downgrade | Neutral -> Sell |
| 2025-08-14 | JMP Securities | Downgrade | Market Outperform -> Market Perform |
| 2025-08-14 | UBS | Maintains | Neutral -> Neutral |
| 2025-08-14 | Needham | Maintains | Buy -> Buy |
| 2025-08-14 | Wells Fargo | Downgrade | Overweight -> Equal-Weight |
| 2025-08-14 | Evercore ISI Group | Downgrade | Outperform -> In-Line |
| 2025-08-14 | Goldman Sachs | Downgrade | Buy -> Neutral |
| 2025-08-14 | B of A Securities | Downgrade | Neutral -> Underperform |
| 2025-05-16 | Goldman Sachs | Maintains | Buy -> Buy |
| 2025-05-15 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2025-05-15 | UBS | Maintains | Neutral -> Neutral |
| 2025-05-15 | Needham | Maintains | Buy -> Buy |
| 2025-05-15 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-04-14 | Goldman Sachs | Maintains | Buy -> Buy |
| 2025-03-10 | Citizens Capital Markets | Reiterate | Market Outperform -> Market Outperform |
| 2025-02-27 | Needham | Maintains | Buy -> Buy |
| 2025-02-27 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-02-27 | Goldman Sachs | Maintains | Buy -> Buy |
| 2025-02-27 | Citigroup | Downgrade | Buy -> Neutral |
| 2025-01-27 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2024-11-14 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2024-11-14 | UBS | Downgrade | Buy -> Neutral |
| 2024-11-14 | Needham | Maintains | Buy -> Buy |
| 2024-11-14 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2024-10-29 | Raymond James | Maintains | Outperform -> Outperform |
| 2024-10-28 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2024-10-14 | Goldman Sachs | Upgrade | Neutral -> Buy |
IBOTTA INC-CL A / IBTA FAQ
What is the average price target for IBOTTA INC-CL A (IBTA) stock?
14 analysts have analysed IBTA and the average price target is 29.73 USD. This implies a price increase of 11.92% is expected in the next year compared to the current price of 26.56.
What is the consensus rating for IBOTTA INC-CL A (IBTA) stock?
The consensus rating for IBOTTA INC-CL A (IBTA) is 51.4286 / 100 . This indicates that analysts generally have a neutral outlook on the stock.
Can you provide the analyst count for IBOTTA INC-CL A stock?
The number of analysts covering IBOTTA INC-CL A (IBTA) is 14.